Registry

Module Specifications

Archived Version 2020 - 2021

Module Title
Module Code
School
Online Module Resources
NFQ level	8	Credit Rating	5
Pre-requisite	None
Co-requisite	None
Compatibles	None
Incompatibles	None

Description

The aim of this module is to provide students with a critical overview of the challenges in administering biopharmaceuticals and strategies for overcoming the main delivery barriers. State of the art concepts for successful formulation and delivery of therapeutic peptides, proteins, nucleic acid-based drugs and vaccines will be described.

Learning Outcomes

1. List the major challenges in delivery of Biopharmaceuticals and explain why advanced delivery systems are needed
2. Describe how protein and peptide injectables may be chemically modified for improved delivery
3. Critically discuss novel non-injectable formulation approaches of peptide and protein drugs
4. Cite clinical trials using chemical and viral vectors for delivery of nucleic acids.
5. Evaluate commercial feasibility of lipid nanoparticles and polymer-based delivery systems for achieving real clinical applications.
6. Explain the role of freeze-drying technology in drug delivery systems

*Type*	*Hours*	*Description*
Workload	Full-time hours per semester
Lecture	16	No Description
Directed learning	109	No Description
Total Workload: 125

All module information is indicative and subject to change. For further information,students are advised to refer to the University's Marks and Standards and Programme Specific Regulations at: http://www.dcu.ie/registry/examinations/index.shtml

Indicative Content and Learning Activities

Lecture
Novel formulation and delivery approaches for peptide and protein injectables

Lecture
Novel non-injectable formulation approaches of peptides and proteins

Lecture
Chemical vectors and Viral technology for delivery of nucleic acids

Lecture
Polymer-Based delivery systems for oral and pulmonary delivery of peptides/proteins/nucleic acids. Role of Freeze drying technology in oral delivery systems.

Assessment Breakdown
Continuous Assessment	%	Examination Weight	%

Type	Description	% of total	Assessment Date
Course Work Breakdown

Reassessment Requirement
Resit arrangements are explained by the following categories; 1 = A resit is available for all components of the module 2 = No resit is available for 100% continuous assessment module 3 = No resit is available for the continuous assessment component
Unavailable

Indicative Reading List

Sindelar, Robert D., editor; Meibohm, Bernd, editor; Crommelin, D. J. A. (Daan J. A) editor: 2013, Pharmaceutical biotechnology: fundamentals and applications, 4, New York: Informa Healthcare, 978-1-4614-64
edited by Michael E. Aulton and Kevin M.G. Taylor.: 2013, Aulton's pharmaceutics: the design and manufacture of medicines, 4, Philadelphia; Churchill Livingstone/Elsevier, 0702042900,
Lene Jorgensen (Editor), Hanne Morck Nielson (Co-Editor): 2009, Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic Acids and Vaccines, 978-0-470-723

Other Resources

None

Programme or List of Programmes

Archives: